Antibiotics

Preliminary research suggests that women who take antibiotics for long periods of time in late adulthood may be at increased risk of death from heart disease and other causes.

Research presented at the 47th Critical Care Congress reveals that PCT-guided antibiotic cessation in critically ill patients resulted in reduced mortality.

Marin H. Kollef, MD, discusses the strongest approach for treating Pseudomonas infections.

Scientists from the NIH and Rutgers New Jersey Medical School are in the process of developing a promising alternative to antibiotic treatments for multidrug-resistant Klebsiella pneumoniae bacteria.

CARB-X, the international partnership between governmental and charitable groups in the United States and the United Kingdom, has announced new funding for the development of new antibiotics to fight drug-resistant bacteria.

High prescribing continues despite the fact that heavy use of these agents can facilitate the development of multidrug-resistant bacteria and tendon, muscle, joint, and central nervous system damage.

Lingering historical concerns have led to inconsistent practices in antibiotic prophylaxis in this population.

Poignant study adds to the growing body of literature that points toward individualizing duration of therapy for each patient.

Dr. Richard Vickers, discusses C. difficile rates in the United Kingdom.